Company / Depreciation & Amortization
Orchestra BioMed Holdings, Inc. Depreciation & Amortization History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$308.0K
FY2025
5-year range
$222.0K / $308.0K
FY2023-FY2025
Trend
+7.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Increased from $222,000 to $308,000 over the past 2 years.
Based on SEC 10-K filings.
$308,000 in FY2025.
Increased from $222,000 to $308,000 over the past 2 years.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, depreciation & amortization increased 7.3% year-over-year.
Company context
Key Data Points
- Altman Z-Score -0.98 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $308.0K | +7.3% |
| FY2024 | $287.0K | +29.3% |
| FY2023 | $222.0K | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026